explore -WSS

explore

author：Wikipedia 2025-09-03 03:36:50 - browse：6748

Photo illustration of three children against a blue background. -- health coverage from STAT — The Pashai children (from left): Abubakar, Mohammad, and Sufyan. Illustration: STAT; Photo Courtesy

On a sweltering day in August 2021, as the engines of a hulking C-17 cargo plane drowned out pops of gunfire and Taliban rocket explosions around them, the young Afghan couple looked down at their 4-month-old son, Mohammad, and felt a shuddering wave of relief. But as the plane lifted above the dusty peaks that hug Kabul like a fortress of sandstone and schist, that feeling grew heavy with grief — for the parents and siblings they were leaving behind, and for Afghanistan, the only home they’d ever known. They did not know when, if ever, they would set foot there again.

Three years later, the Pashais are fearing for their family’s lives once again. This time the existential threat they face isn’t war, but a pair of faulty genes, silently passed down through their families for generations before detonating on American soil.

In October, Mohammad was diagnosed with a rare inherited disorder — metachromatic leukodystrophy. Genetic tests revealed his youngest brother, Sufyan, though he’s showing no symptoms, also has the disease. There’s a potential cure for Sufyan, a company offering it free of charge, and a team of doctors in Minnesota ready to administer it. But the Medicaid program in the Pashais’ new home state of Texas has said it won’t cover the cost of even an initial consult to confirm he’s a good candidate for the treatment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Scientists unlock the key to scar

knowledge

entertainment

WSS

Medicare Advantage coverage denials need scrutiny, senators say

An inside look at PIPEs, biotech's buzzy new financing tool

AstraZeneca loses challenge to Medicare drug price negotiation

Stories you might have missed in 2023: health, science, medicine

Hospital chaplains balance Covid safety with patients’ spiritual needs

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

explore

explore

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

STAT Virtual Event: JPM Recap, Live!

The cancer drug shortage isn’t new — and neither are the solutions

Covid isolation guidance eased by the CDC

In age of alternative facts, a scholarly course on calling out crap

Nonprofit, backed by Microsoft, to certify AI tools in health care

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Flu vaccine offering decent levels of protection this winter, new data show

Peter Hotez and the public health issue of online harassment

Flu vaccine offering decent levels of protection this winter, new data show

hotspot

AstraZeneca loses challenge to Medicare drug price negotiation

FDA early review: GLP

FDA early review: GLP

At JPM 2024, hospital systems pitch financial strength to investors

Profiling embryos to choose those with higher IQs is almost a reality

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

knowledge

knowledge

entertainment

entertainment